Effect | Decrease |
Trial Design | Double blind |
Trial Length | 1-6 months |
Number of Subjects | 80 |
Sex | Both Genders |
Age Range | 45-64, 65+ |
Body Types | Overweight |
Supplementation of rose hip powder at a dosage of 2,500mg twice daily (5g total) for three months in persons over 35 with hip or knee osteoarthritis was associated with a 13% reduction in symptoms as assessed by WOMAC relative to placebo. Paracetamol usage as rescue medication was reduced by 40% in the rose hip group, and no changed were observed on any parameter in placebo.Funding issues for this study:
Supplements provided by a producer, but study conducted independently